Matrix metalloproteinases as breast cancer drivers and therapeutic targets.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Frontiers in Bioscience

• Publication date

  2015-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2741/4364PMID 25961550PMCID PMC4516284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Architecture and function of metallopeptidase catalytic domains

  2014cited by this paper
• Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients.

  2014cited by this paper
• ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-κB-dependent activation of Snail

  2014cited by this paper
• Protein-tyrosine Pseudokinase 7 (PTK7) Directs Cancer Cell Motility and Metastasis*

  2014cited by this paper
• Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state

  2014cited by this paper
• Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer

  2014cited by this paper
• Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma

  2014cited by this paper
• Molecular mechanisms of epithelial–mesenchymal transition

  2014cited by this paper
• Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors

  2014cited by this paper
• Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer

  2014cited by this paper
• Affinity- and Specificity-Enhancing Mutations Are Frequent in Multispecific Interactions between TIMP2 and MMPs

  2014cited by this paper
• TIMP-1 via TWIST1 Induces EMT Phenotypes in Human Breast Epithelial Cells

  2014cited by this paper
• MMP-9 expression varies according to molecular subtypes of breast cancer

  2014cited by this paper
• Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood–brain barrier

  2014cited by this paper
• Tissue Inhibitors of Metalloproteinases (TIMPs): Inhibition of Zn‐Dependent Metallopeptidases

  2014cited by this paper
• Matrix Metalloproteinase-10/TIMP-2 Structure and Analyses Define Conserved Core Interactions and Diverse Exosite Interactions in MMP/TIMP Complexes

  2013cited by this paper
• TIMP-1 attenuates blood–brain barrier permeability in mice with acute liver failure

  2013cited by this paper
• Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study

  2013cited by this paper
• Extracellular matrix proteins regulate epithelial-mesenchymal transition in mammary epithelial cells.

  2013cited by this paper
• Adipose tissue and adipocytes support tumorigenesis and metastasis.

  2013cited by this paper
• The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90β.

  2013cited by this paper
• High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients

  2013cited by this paper
• MEROPS: the database of proteolytic enzymes, their substrates and inhibitors

  2013cited by this paper
• Crystal structure of full‐length human collagenase 3 (MMP‐13) with peptides in the active site defines exosites in the catalytic domain

  2013cited by this paper
• Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking

  2013cited by this paper
• Unraveling hidden regulatory sites in structurally homologous metalloproteases.

  2013cited by this paper
• Regulation of mechanical stress by mammary epithelial tissue structure controls breast cancer cell invasion

  2013cited by this paper
• Triggering the landslide: The tumor-promotional effects of myofibroblasts.

  2013influential reference
• Targeting a Single Function of the Multifunctional Matrix Metalloprotease MT1-MMP

  2013cited by this paper
• A role for matrix metalloproteinases in regulating mammary stem cell function via the Wnt signaling pathway.

  2013cited by this paper
• Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies.

  2013cited by this paper
• A monoclonal antibody interferes with TIMP-2 binding and incapacitates the MMP-2-activating function of multifunctional, pro-tumorigenic MMP-14/MT1–MMP

  2013cited by this paper
• Targeting the Fas/FasL signaling pathway in cancer therapy

  2012cited by this paper
• Insights into Ectodomain Shedding and Processing of Protein-tyrosine Pseudokinase 7 (PTK7)*

  2012cited by this paper
• The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

  2012cited by this paper
• Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth.

  2012cited by this paper
• Matrix compliance regulates Rac1b localization, NADPH oxidase assembly, and epithelial–mesenchymal transition

  2012cited by this paper
• Structural basis for matrix metalloproteinase 1-catalyzed collagenolysis.

  2012cited by this paper
• Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1

  2012cited by this paper
• TGFβ signalling in context

  2012cited by this paper
• Simple Pseudo-dipeptides with a P2′ Glutamate

  2012cited by this paper
• Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/β-catenin signaling

  2012cited by this paper
• Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.

  2012cited by this paper
• Tumor cell vasculogenic mimicry: from controversy to therapeutic promise.

  2012cited by this paper
• New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression.

  2012cited by this paper
• Matrix Metalloproteinase Induction of Rac1b, a Key Effector of Lung Cancer Progression

  2012cited by this paper
• Identification of collagen binding domain residues that govern catalytic activities of matrix metalloproteinase-2 (MMP-2).

  2012cited by this paper
• Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases.

  2012cited by this paper
• Neuroprotection from tissue inhibitor of metalloproteinase-1 and its nanoparticles.

  2012cited by this paper
• Involvement of hnRNP A1 in the matrix metalloprotease‐3‐dependent regulation of Rac1 pre‐mRNA splicing

  2012cited by this paper
• PEGylation Extends Circulation Half-Life While Preserving In Vitro and In Vivo Activity of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1)

  2012cited by this paper
• Peptide-Based Selective Inhibitors of Matrix Metalloproteinase-Mediated Activities

  2012cited by this paper
• Matrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2

  2012cited by this paper
• Role of serum matrix metalloproteinase-2 and -9 to predict breast cancer progression.

  2011cited by this paper
• Microenvironment and Immunology Cancer-Associated Adipocytes Exhibit an Activated Phenotype and Contribute to Breast Cancer Invasion

  2011cited by this paper
• Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

  2011cited by this paper
• Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential

  2011cited by this paper
• Phage Display of Tissue Inhibitor of Metalloproteinases-2 (TIMP-2)

  2011cited by this paper
• Inhibition of Matrix Metalloproteinase 14 (MMP-14)-mediated Cancer Cell Migration*

  2011cited by this paper
• The Interface between Catalytic and Hemopexin Domains in Matrix Metalloproteinase-1 Conceals a Collagen Binding Exosite*

  2011cited by this paper
• Tumor angiogenesis: molecular pathways and therapeutic targets

  2011cited by this paper
• MEROPS: the database of proteolytic enzymes, their substrates and inhibitors

  2011cited by this paper
• Faculty Opinions recommendation of Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis.

  2011cited by this paper
• Pharmacokinetics and biodistribution of human serum albumin-TIMP-2 fusion protein using near-infrared optical imaging.

  2011cited by this paper
• Exosite Interactions Impact Matrix Metalloproteinase Collagen Specificities*

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9.

  2011cited by this paper
• MMP-1 expression has an independent prognostic value in breast cancer

  2011cited by this paper
• Localizing matrix metalloproteinase activities in the pericellular environment

  2011cited by this paper
• Survival differences among women with de novo stage IV and relapsed breast cancer.

  2010cited by this paper
• The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function.

  2010cited by this paper
• Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1' cavity.

  2010cited by this paper
• The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment.

  2010cited by this paper
• Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells.

  2010cited by this paper
• To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition.

  2010cited by this paper
• Matrix metalloproteinases: fold and function of their catalytic domains.

  2010cited by this paper
• Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition?

  2010cited by this paper
• The 19-Amino Acid Insertion in the Tumor-associated Splice Isoform Rac1b Confers Specific Binding to p120 Catenin*

  2010cited by this paper
• Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer

  2010cited by this paper
• Insights from Selective Non-phosphinic Inhibitors of MMP-12 Tailored to Fit with an S1′ Loop Canonical Conformation*

  2010cited by this paper
• The Wnt/Planar Cell Polarity Protein-tyrosine Kinase-7 (PTK7) Is a Highly Efficient Proteolytic Target of Membrane Type-1 Matrix Metalloproteinase

  2010cited by this paper
• NMR and Bioinformatics Discovery of Exosites That Tune Metalloelastase Specificity for Solubilized Elastin and Collagen Triple Helices*

  2010cited by this paper
• The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.

  2010influential reference
• Matrix metalloproteinases: regulators of the tumor microenvironment.

  2010influential reference
• Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion.

  2010cited by this paper
• Molecular Mechanism of Type I Collagen Homotrimer Resistance to Mammalian Collagenases*

  2010cited by this paper
• Role of Matrix Metalloproteinase-9 Dimers in Cell Migration

  2010cited by this paper
• Interdomain Flexibility in Full-length Matrix Metalloproteinase-1 (MMP-1)*

  2009cited by this paper
• Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.

  2009cited by this paper
• Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells.

  2009cited by this paper
• Potassium Channel Modulation by a Toxin Domain in Matrix Metalloprotease 23*

  2009cited by this paper
• Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease

  2009cited by this paper
• Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas

  2009cited by this paper
• Identification of Specific Hemopexin-like Domain Residues That Facilitate Matrix Metalloproteinase Collagenolytic Activity*

  2009cited by this paper
• Intra- and interdomain flexibility in matrix metalloproteinases: functional aspects and drug design.

  2009cited by this paper
• Supervised risk predictor of breast cancer based on intrinsic subtypes.

  2009cited by this paper
• Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.

  2009cited by this paper
• Prognostic significance of MMP‐9 and TIMP‐1 serum and tissue expression in breast cancer

  2008cited by this paper
• Membrane Type 1 Matrix Metalloproteinase Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer*

  2008cited by this paper
• VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis.

  2008cited by this paper

• Meme Kanseri Gelişiminde ve Tedavisinde İntegrinlerin Rolü

  2026cites this paper
• The role of hsa_circ_0000520 in breast cancer progression: insights into the miR-542-3p/TMBIM6 regulatory axis.

  2025cites this paper
• Therapeutic potential of inhibitors of gelatinases MMP-2 and MMP-9 for the treatment of breast cancer.

  2025cites this paper
• Engineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma Activity

  2025cites this paper
• The pleiotropic roles of non-hormonal receptor basigin and regulatory microRNAs in breast cancer

  2025cites this paper
• Targeting EGFR/IGF-IR Functional Crosstalk in 2D and 3D Triple-Negative Breast Cancer Models to Evaluate Tumor Progression

  2025cites this paper
• Metal-based antibody, nanobody, and peptide conjugates: Potential for breast cancer therapy.

  2025cites this paper
• Cardiac function and extracellular matrix morphology are altered by chronic high fat diet in Drosophila larvae

  2025cites this paper
• OCT‐2 Is Associated With Pro‐Metastatic Epigenomic Properties of Triple‐Negative Breast Cancer Cells

  2025cites this paper
• CXCR4/CXCL12 blockade therapy; a new horizon in TNBC therapy

  2025cites this paper
• Genetic Insights into Breast Cancer in Northeastern Mexico: Unveiling Gene–Environment Interactions and Their Links to Obesity and Metabolic Diseases

  2025cites this paper
• Narrative review of 3D bioprinting for the construction of in vitro tumor models: present and prospects

  2025cites this paper
• Discoid Domain Receptors Signaling in Macrophages-Mediated Diseases

  2025cites this paper
• Inhibitory Effects of Different Doses of Matrine on Breast Cancer and Its Relationship with miR-188

  2025cites this paper
• Implications of Mineralization Biomarkers in Breast Cancer Outcomes Beyond Calcifications

  2025cites this paper
• Structurally decoupled hyaluronic acid hydrogels for studying matrix metalloproteinase-mediated invasion of metastatic breast cancer cells.

  2024cites this paper
• Endothelial-to-mesenchymal transition in the tumor microenvironment: Roles of transforming growth factor-β and matrix metalloproteins

  2024cites this paper
• Identification and validation of matrix metalloproteinase hub genes as potential biomarkers for Skin Cutaneous Melanoma

  2024cites this paper
• Induction of Invasive Basal Phenotype in Triple-Negative Breast Cancers by Long Noncoding RNA BORG

  2024cites this paper
• The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma

  2024cites this paper
• The role of polymorphic markers of matrix metalloproteinase genes in the tumoral progression of breast cancer

  2024cites this paper
• Onco-Breastomics: An Eco-Evo-Devo Holistic Approach

  2024cites this paper
• Metalloproteinases as Biomarkers and Sociomarkers in Human Health and Disease

  2024cites this paper
• Targeting cholesterol impairs cell invasion of all breast cancer types

  2024cites this paper
• Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer—directs the road towards therapy resistance, metastatic progression and recurrence

  2024cites this paper
• Matrix metalloproteinases as therapeutic targets in breast cancer

  2023cites this paper
• Development of a peptide microarray-based metal-enhanced fluorescence assay for ultrasensitive detection of multiple matrix metalloproteinase activities by using a gold nanorod-polymer substrate.

  2023cites this paper
• Metabolically healthy/unhealthy obesity and breast cancer: A possible role of plasma-derived extracellular vesicles on the cancerous behavior of triple-negative breast cancer.

  2023cites this paper
• The cytotoxic potential of sinapic acid on luminal A breast cancer; a computational and experimental pharmacology approach

  2023cites this paper
• Modern understanding of risk factors and mechanisms of breast cancer development

  2023cites this paper
• Exosomes isolated from metabolically unhealthy normal weight and overweight phenotypes deteriorate the ER/PR positive breast cancer behavior

  2023cites this paper
• Associations of Polymorphic Loci of Matrix Metalloproteinase Genes with the Development of Breast Cancer in Women Central Chernozem Region of Russia

  2023cites this paper
• Exosomes modified with anti-MEK1 siRNA lead to an effective silencing of triple negative breast cancer cells.

  2023cites this paper
• Interaction between Macrophages and Adipose Stromal Cells Increases the Angiogenic and Proliferative Potential of Pregnancy-Associated Breast Cancers

  2023cites this paper
• Mechanisms Of Breast Cancer Progression Induced BY Environment-Polluting ARYL Hydrocarbon Receptor Agonists.

  2023cites this paper
• Associations of Polymorphic Loci of Matrix Metalloproteinase Genes with Breast Cancer in Women of the Central Black Earth Region of Russia

  2023cites this paper
• Simultaneous quantification of exosomal MMP14 expression and proteolysis activity on a spherical dual-probe-based fluorescent nanosensor.

  2023cites this paper
• Gold Nanoparticles Inhibit PMA-Induced MMP-9 Expression via microRNA-204-5p Upregulation and Deactivation of NF-κBp65 in Breast Cancer Cells

  2023cites this paper
• Spatially patterned 3D model mimics key features of cancer metastasis to bone.

  2023cites this paper
• Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer

  2023cites this paper
• Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression

  2023cites this paper
• Combating breast cancer progression through combination therapy with hypomethylating agent and glucocorticoid

  2023cites this paper
• The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer

  2023cites this paper
• A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer

  2023cites this paper
• ESR2 Drives Mesenchymal-to-Epithelial Transition in Triple-Negative Breast Cancer and Tumorigenesis In Vivo

  2022cites this paper
• Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer

  2022cites this paper
• Matrix Metalloproteinase Gene Polymorphisms Are Associated with Breast Cancer in the Caucasian Women of Russia

  2022cites this paper
• The Modifying Effect of Obesity on the Association of Matrix Metalloproteinase Gene Polymorphisms with Breast Cancer Risk

  2022cites this paper
• Extracellular matrix-natural killer cell interactome: an uncharted territory in health and disease.

  2022cites this paper
• Engineering of tissue inhibitor of metalloproteinases TIMP-1 for fine discrimination between closely related stromelysins MMP-3 and MMP-10

  2022cites this paper
• Polymorphism rs1940475 of the MMP8 gene is a protective factor of severe breast cancer

  2022cites this paper
• The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer

  2022cites this paper
• Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities

  2022cites this paper
• Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells

  2021cites this paper
• Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance

  2021cites this paper
• The Adipose Microenvironment Dysregulates the Mammary Myoepithelial Cells and Could Participate to the Progression of Breast Cancer

  2021cites this paper
• Potential Role of Phytochemicals Against Matrix Metalloproteinase Induced Breast Cancer; An Explanatory Review

  2021cites this paper
• Matrix degradation and cell proliferation are coupled to promote invasion and escape from an engineered human breast microtumor.

  2021cites this paper
• The action of hyaluronan in functional properties, morphology and expression of matrix effectors in mammary cancer cells depends on its molecular size

  2021cites this paper
• Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives

  2021cites this paper
• Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer

  2021cites this paper
• Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast Cancer

  2021cites this paper
• Metalloproteinases 1 and 3 as Potential Biomarkers in Breast Cancer Development

  2021cites this paper
• Sauchinone inhibits the proliferation, migration and invasion of breast cancer cells by suppressing Akt-CREB-MMP13 signaling pathway

  2021cites this paper
• Comprehensive Analysis to Identify the Epithelial–Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma

  2021cites this paper
• A Marine λ-Oligocarrageenan Inhibits Migratory and Invasive Ability of MDA-MB-231 Human Breast Cancer Cells through Actions on Heparanase Metabolism and MMP-14/MMP-2 Axis

  2021cites this paper
• Biological Mechanisms and Therapeutic Opportunities in Mammographic Density and Breast Cancer Risk

  2021cites this paper
• Enyzmes | Matrix Metalloproteinases

  2021cites this paper
• Dual Targeting of Cancer Cells and MMPs with Self-Assembly Hybrid Nanoparticles for Combination Therapy in Combating Cancer

  2021cites this paper
• Hold on or Cut? Integrin- and MMP-Mediated Cell–Matrix Interactions in the Tumor Microenvironment

  2020cites this paper
• MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation

  2020cites this paper
• Whole-genome screen identifies diverse pathways that negatively regulate ciliogenesis

  2020cites this paper
• Dietary fat and obesity as modulators of breast cancer risk: Focus on DNA methylation

  2020cites this paper
• Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer.

  2020cites this paper
• Emerging roles of ECM remodeling processes in cancer.

  2020cites this paper
• High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkers

  2020cites this paper
• The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies

  2020cites this paper
• Phycocyanin C a Natural Product with Impressive Therapeutic Efficacy for Inhibition of Breast Tumors’ Growth and Metastasis in Vivo

  2020cites this paper
• ΕGFR/ERβ-Mediated Cell Morphology and Invasion Capacity Are Associated with Matrix Culture Substrates in Breast Cancer

  2020cites this paper
• The Premature Senescence in Breast Cancer Treatment Strategy

  2020cites this paper
• Association between Matrix Metalloproteinas-2 Gene Variants and Pathogenesis of Breast Cancer in Sera of Iraqi Women

  2020cites this paper
• Knockout of MMP3 Weakened Solid Tumor Organoids and Cancer Extracellular Vesicles

  2020cites this paper
• Immunoexpression of metalloproteinases 9 (MMP-9) and 2 (MMP-2) and their inhibitors (TIMP-1 and TIMP-2) in normal and neoplastic canine mammary tissue

  2020cites this paper
• Influence of Fibroblasts on Mammary Gland Development, Breast Cancer Microenvironment Remodeling, and Cancer Cell Dissemination

  2020cites this paper
• Plasma Matrilysins MMP-7 and MMP-26 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients

  2020cites this paper
• A Glance on the Role of Bacterial Siderophore from the Perspectives of Medical and Biotechnological Approaches.

  2020cites this paper
• Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics

  2020cites this paper
• Knockout of MMP3 Weakens Solid Tumor Organoids and Cancer Extracellular Vesicles

  2020cites this paper
• Abnormal Hypermethylation of CpG Dinucleotides in Promoter Regions of Matrix Metalloproteinases Genes in Breast Cancer and its Relation to Epigenomic Subtypes and HER2 Overexpression

  2020cites this paper
• Breast Fibroblasts and ECM Components Modulate Breast Cancer Cell Migration through the Secretion of MMPs in a 3D Microfluidic Co-Culture Model

  2020cites this paper
• MOSTWAS: Multi-Omic Strategies for Transcriptome-Wide Association Studies

  2020cites this paper
• Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets

  2020cites this paper
• Natural Killer Cell Defects in Breast Cancer: A Key Pathway for Tumor Evasion

  2020cites this paper
• A protective polymorphism in MMP16, improved blood gas levels, and chronic obstructive pulmonary diseases: Family and two population‐based studies

  2020cites this paper
• IL-18 immunoadjuvanted xenogeneic canine MMP-7 DNA vaccine overcomes immune tolerance and supresses the growth of murine mammary tumor.

  2020cites this paper
• Inflammatory Microenvironment Modulation of Alternative Splicing in Cancer: A Way to Adapt.

  2020cites this paper
• Plasma Level of MMP-10 May Be a Prognostic Marker in Early Stages of Breast Cancer

  2020cites this paper
• MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1.

  2020cites this paper
• The extracellular matrix in tumor progression and metastasis

  2019cites this paper
• EFEMP2 promotes colon cancer cell invasion and growth through the ERK1/2 signaling pathway.

  2019cites this paper